Back to Search
Start Over
Ginsenoside Rh1: A Systematic Review of Its Pharmacological Properties
- Source :
- Planta medica. 84(3)
- Publication Year :
- 2018
-
Abstract
- Ginsenoside Rh1 is one of major bioactive compounds extracted from red ginseng, which has been increasingly used for enhancing cognition and physical health worldwide. The objective of this study was to review the pharmacological effects of ginsenoside Rh1 in a systematic manner. We performed searches on eight electronic databases including MEDLINE (Pubmed), Scopus, Google Scholar, POPLINE, Global Health Library, Virtual Health Library, the System for Information on Grey Literature in Europe, and the New York Academy of Medicine Grey Literature Report to select the original research publications reporting the biological and pharmacological effects of ginsenoside Rh1 from in vitro and in vivo studies regardless of publication language and study design. Upon applying the inclusion and exclusion criteria, we included a total of 57 studies for our systemic review. Ginsenoside Rh1 exhibited the potent characteristics of anti-inflammatory, antioxidant, immunomodulatory effects, and positive effects on the nervous system. The cytotoxic effects of ginsenoside Rh1 were dependent on different types of cell lines. Other pharmacological effects including estrogenic, enzymatic, anti-microorganism activities, and cardiovascular effects have been mentioned, but the results were considerably diverged. A higher quality of evidence on clinical trial studies is highly recommended to confirm the consistent efficacy of ginsenoside Rh1.
- Subjects :
- 0301 basic medicine
Ginsenosides
MEDLINE
Pharmaceutical Science
Panax
Pharmacology
Original research
Nervous System
Antioxidants
Analytical Chemistry
law.invention
03 medical and health sciences
chemistry.chemical_compound
Ginseng
0302 clinical medicine
law
Drug Discovery
Medicine
Animals
Humans
Immunologic Factors
Plants, Medicinal
business.industry
Organic Chemistry
Physical health
Estrogens
Antineoplastic Agents, Phytogenic
Quality of evidence
Clinical trial
030104 developmental biology
Complementary and alternative medicine
chemistry
Ginsenoside
030220 oncology & carcinogenesis
Molecular Medicine
business
Phytotherapy
Subjects
Details
- ISSN :
- 14390221
- Volume :
- 84
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Planta medica
- Accession number :
- edsair.doi.dedup.....816eb75bffdd43d7f4d9a84fbe835731